Canine insulinoma

Compendium on Continuing Education for the Practicing Veterinarian

Volumn 18, Issue 1, 1996, Pages 13-24

  Steiner, Jörg M ^a   Bruyette, David S ^b,c,d  

^a PURDUE UNIVERSITY   (United States)

^b KANSAS STATE UNIVERSITY   (United States)

^c Amer Coll of Vet Int Medicine

^d Vet Internal Medical Specialists   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0003899960     PISSN: 01931903     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Moore FM, Dayal Y, Shelton JC: Pancreatic endocrine tumors in dogs: An immunohistochemical analysis. Lab Invest 52: 44A-45A, 1985.
2. Hawkins KL, Summers BA, Kuhajda FP, et al: Immunocytochemistry of normal pancreatic islets and spontaneous islet cell tumors in dogs. Vet Pathol 24:170-179, 1987.
3. Zerbe CA, Boosinger TR, Grabau JH, et al: Pancreatic polypeptide and insulin secreting tumor in a dog with duodenal ulcers and hypertrophic gastritis. J Vet Intern Med 3:178-182, 1989.
4. Feldman EC, Nelson RW: Hypoglycemia, in Feldman EC, Nelson RW (eds): Canine and Feline Endocrinology and Reproduction. Philadelphia, WB Saunders Co, 1987, pp 304-327.
5. Davis MR, Shamoon H: Deficient counterregulatory hormone responses during hypoglycemia in a patient with insulinoma. J Clin Endocrinol Met 72:788-792, 1991.
6. Eigenmann JE: Metabole and endokrine Ursachen von neurologischen Erkrankungen. Kleintierpraxis 29:179-197, 1984.
7. Jordan D, Carithers RW: Canine insulinoma. Iowa State Vet 2:70-73, 1980.
8. Rogers KS, Luttgen PJ: Hyperinsulinism. Compend Contin Educ Pract Vet 7(10):829-840, 1985.
9. Mattheeusws D, Rottiers R, DeRijcke J, et al: Hyperinsulinism in the dog due to pancreatic islet cell tumor. J Small Anim Pract 7:313-318, 1976.
10. Huxtable CR, Farrow BRH: Functional neoplasms of the canine pancreatic-islet beta-cell. J Small Anim Pract 20:737-748, 1979.
11. Caywood DD, Wilson JW, Hardy RM, et al: Pancreatic islet cell adenocarcinoma: Clinical and diagnostic features of six cases. JAVMA 174:714-717, 1979.
12. Chrisman CL: Postoperative results and complications of insulinomas in dogs. JAAHA 16:677-684, 1980.
13. Steinberg HS: Insulin secreting pancreatic tumors in the dog. JAAHA 16:695-698, 1980.
14. Prescott CW, Thompson HL: Insulinoma in the dog. Aust Vet J 56:502-505, 1980.
15. Kruth SA, Feldman EC, Kennedy PC: Insulin-secreting islet cell tumors: Establishing a diagnosis and the clinical course for 25 dogs. JAVMA 181:54-58, 1982.
16. Leifer CE, Peterson ME, Matus RE: Insulin-secreting tumor: Diagnosis and medical and surgical management in 55 dogs. JAVMA 188:60-64, 1986.
17. Caywood DD, Klausner JS, O'Leary TP, et al: Pancreatic insulin-secreting neoplasms: Clinical, diagnostic, and prognostic features. JAAHA 24:577-584, 1988.
18. Wheeler SL: Pancreatic insulin-secreting neoplasms, in Withrow SF, MacEwen EG (eds): Clinical Veterinary Oncology. Philadelphia, JB Lippincott Co, 1987, pp 268-273.
19. Priester WA: Pancreatic islet cell tumors in domestic animals. J Natl Cancer Inst 53:227-229, 1974.
20. Teunissen GBH, Hendriks HJ, DeBruijne JJ: Hypoglycaemie and Insulinom. Kleintierpraxis 25:447-454, 1980.
21. Zerbe CA: Islet cell tumors secreting insulin, pancreatic polypeptide, gastrin, or glucagon. Unpublished data, Auburn University, Auburn, AL, 1991.
22. Shahar R, Rousseaux C, Steiss J: Peripheral polyneuropathy in a dog with functional islet β-cell tumor and widespread metastasis. JAVMA 187:175-177, 1985.
23. Braund KG, McGuire JA, Amling KA, et al: Peripheral neuropathy associated with malignant neoplasms in dogs. Vet Pathol 24:16-21, 1987.
24. Schrauwen E: Clinical peripheral polyneuropathy associated with canine insulinoma. Vet Rec 128:211-212, 1991.
25. Braund KG, Steiss J, Amling KA, et al: Insulinoma and subclinical peripheral neuropathy in two dogs. J Vet Intern Med 1:86-90, 1987.
26. Fajans SS, Floyd JC: Fasting hypoglycemia in adults. N Engl J Med 24:747-760, 1976.
27. Best JD, Chrisholm DJ, Alford FP: Insulinoma: Poor recognition of clinical features is the major problem in diagnosis. Med J Aust 2:1-5, 1978.
28. Breitschwerdt EB, Loar AS, Hribernik TN, et al: Hypoglycemia in four dogs with sepsis. JAVMA 178:1072-1076, 1981.
29. Edwards DF: It's time to unamend the insulin-glucose ratio. JAVMA 188:951-953, 1986.
30. Zanesco S, Freudiger U: Der intravenoese Glucose-Toleranztest und Insulin-Antwort bei Hunden. III. Mitteilung. Kleintierpraxis 31:223-232, 1986.
31. Fingeroth JM, Smeak DD: Intravenous methylene blue infusion for intraoperative identification of pancreatic islet-cell tumors in dogs. JAAHA 24:175-182, 1988.
32. Smeak DD, Fingeroth JM, Bilbrey SA: Intravenous methylene blue as a specific stain for primary and metastatic insulinoma in the dog. JAAHA 24:478-480, 1988.
33. Vinik AI, Delbridge L, Moattari AR, et al: Transhepatic portal vein catheterization for localization of insulinomas: A ten-year experience. Surgery 109:1-11, 1991.
34. Balthazar EJ, Chako AC: Computed tomography of pancreatic masses. Am J Gastroenterol 85:343-349, 1990.
35. Doppman JL, Shawker TH, Miller DL: Localization of islet cell tumors. Gastroenterol Clin North Am 18:793-803, 1989.
36. Wilms G, Baert AL, Dardenne AR, et al: Percutaneous transhepatic venous sampling of the pancreas in localizing insulinomas. J Belge Radiol 73:453-457, 1990.
37. Doppman JL, Miller DL, Chang R, et al: Insulinomas: Localization with select intraarterial injection of calcium. Radiology 178:237-241, 1991.
38. Kung AWC, Chan FL, Tam CF, et al: Case report: Localization of occult insulinoma by intraarterial stimulation with calcium and venous sampling technique. Clin Radiol 46:55-56, 1992.
39. 131I-metaiodobenzylguanidine. Clin Nucl Med 14:903-905, 1989.
40. Ogawa Y, Tanaka M, Matsumoto S, et al: Islet cell tumors of the pancreas. The diagnostic value of endoscopic retrograde pancreatography. Int J Pancreatol 6:49-60, 1990.
41. Glover JR, Shorvon PJ, Lees WR: Localization of islet cell tumors by endoscopic ultrasonography. Gastroenterology 103: 711-712, 1992.
42. Roesch T, Lightdale CJ, Botet JF, et al: Localization of pancreatic endocrine tumors by endoscopic ultrasonography. N Engl J Med 326: 1721-1726, 1992.
43. Dunnington GL: Intraoperative ultrasonography in abdominal surgery. Surg Annu 25.1:101-125, 1993.
44. Boettger TC, Weber W, Beyer J, et al: Value of tumor localization in patients with insulinoma. World J Surg 14:107-114, 1990.
45. Matthiesen DT, Mullen HS: Problems and complications associated with endocrine surgery in the dog and cat. Probl Vet Med 2:627-667, 1990.
46. Mehlhaff CF, Peterson ME, Patnaik AK, et al: Insulin-producing islet cell neoplasms: Surgical considerations and general management in 35 dogs. JAAHA 21:607-612, 1985.
47. Eloy R, Bouchet P, Clendinnen G, et al: New technique of total pancreatectomy without duodenectomy in the dog. Am J Surg 140:409-412, 1980.
48. Meyer DJ: Pancreatic islet cell carcinoma in a dog treated with streptozotocin. Am J Vet Res 37:1221-1223, 1976.
49. Meyer DJ: Temporary remission of hypoglycemia in a dog with an insulinoma after treatment with streptozotocin. Am J Vet Res 38:1201-1203, 1977.
50. Meleo K: Management of insulinoma patients with refractory hypoglycemia. Probl Vet Med 2:602-609, 1990.
51. Moertel CG, Lefkopoulo M, Lipsitz S, et al: Streptozotocin-doxorubicin, streptozotocin-fluorouracil, or chlorozotocin in the treatment of advanced islet-cell carcinoma. N Engl J Med 326:519-523, 1992.
52. Ajani JA, Levin B, Wallace S: Systemic and regional therapy of advanced islet cell tumor. Gastroenterol Clin North Am 18: 923-930, 1989.
53. Vinik AI, Moattari AR: Treatment of endocrine tumors of the pancreas. Endocrinol Metab Clin North Am 18:483-495, 1989.
54. Marsh RW, Killeen RB: Efficacy of the combination of carboplatin and cyclophosphamide in the treatment of metastatic insulinoma. Cancer Invest 10:523-524, 1992.
55. Tennvall J, Ljungberg O, Ahren B, et al: Radiotherapy for unresectable endocrine pancreatic carcinomas. Eur J Surg Oncol 18:73-76, 1992.
56. Crapo PA, Reaven G, Olefsky J, et al: Plasma glucose and insulin responses to orally administered simple and complex carbohydrates. Diabetes 25:741-747, 1976.
57. Nelson RW, Foodman MS: Medical management of canine hyperinsulinism. JAVMA 187:78-82, 1985.
58. Altsulzer N, Hampshire J, Moraru E: On the mechanism of diazoxide-induced hyperglycemia. Diabetes 26:931-935, 1977.
59. Parker AJ, O'Brien D, Musselman EE: Diazoxide treatment of metastatic insulinoma in the dog. JAAHA 18:315-318, 1982.
60. Maton PM: The use of the long-acting somatostatin analogue, octerotide acetate in patients with islet cell tumors. Gastroenterol Clin North Am 18:897-921, 1989.
61. Lothrop CD: Medical treatment of neuroendocrine tumors of the gastroenteropancreatic system with somatostatin, in Kirk RW (ed): Current Veterinary Therapy. X. Philadelphia, WB Saunders Co, 1989, pp 1020-1024.
62. Haskell CM: L-Asparaginase: Human toxicology and single agent activity in nonleucemic neoplasms. Cancer Treat Rep 65(Suppl 4):57-59, 1981.
63. Blum I, Doron M, Laron Z, et al: Prevention of hypoglycemia attacks by propranolol in a patient suffering from insulinoma. Diabetes 24:535-537, 1975.
64. Ulbrecht JS, Schmeltz R, Aarons JH, et al: Insulinoma in a 94-year-old woman: Long-term therapy with verapamil. Diato Care 9:196-199, 1986.